Holoeyes, Inc.

Holoeyes, Inc. is a Tokyo-based company specializing in virtual reality (VR) solutions that enhance communication in clinical settings and medical education. Their innovative products aid healthcare professionals in surgical planning and training. Founded in 2016 in Tokyo, Japan, Holoeyes, Inc.

focuses on providing VR solutions for the healthcare sector. The company was established by Maki Sugimoto and Naoji Taniguchi. In June 2025, Holoeyes, Inc. raised an undisclosed amount in series B funding from new investors Knowledge Initiative for Teikyo Technology and Wacom Technology Corporation, with participation from other individual investors.

Holoeyes, Inc. specializes in virtual reality (VR) solutions aimed at revolutionizing communication in clinical settings and medical education. The company's flagship products include Holoeyes MD and Holoeyes Edu, which facilitate preoperative simulations and remote collaboration among medical professionals. Holoeyes MD allows for the three-dimensional reconstruction of human anatomical data from clinical imaging, providing surgeons with a closer representation of the actual surgical field compared to traditional two-dimensional images.

Holoeyes Edu serves as a comprehensive VR education platform for medical students, residents, and young physicians, enabling them to learn advanced surgical techniques and anatomy using affordable VR headsets. The company's solutions are utilized primarily in Japan but are also being introduced to markets in North America and Europe, catering to healthcare institutions, educational organizations, and individual medical practitioners. Holoeyes generates revenue through a combination of direct sales and partnerships with healthcare institutions and educational organizations. The company operates on a subscription-based model for its software products, offering various pricing plans tailored to institutional use, which may include licenses for shared access among multiple users.

Additionally, the firm provides demo experiences to medical professionals, facilitating engagement and potential conversions into long-term clients. Holoeyes' core products, such as Holoeyes MD and Holoeyes Edu, are marketed to medical facilities and educational institutions, establishing a B2B relationship that supports ongoing training and procedural planning in healthcare. The company plans to use its proceeds from June 2025 funding to continue its product and services development, strengthen its collaboration with medical institutions and enterprises, and to expand its business globally.